Drug Shortage Report for MOXIFLOXACIN INJECTION

Last updated on 2022-09-22 History
Report ID 152362
Drug Identification Number 02433087
Brand name MOXIFLOXACIN INJECTION
Common or Proper name Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 400MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-10-05
Estimated end date 2023-01-31
Actual end date
Shortage status Actual shortage
Updated date 2022-09-22
Company comments On 150% allocation.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-07 English Compare
v2 2022-01-07 French Compare
v3 2022-01-07 English Compare
v4 2022-01-07 French Compare
v5 2022-01-07 English Compare
v6 2022-01-07 French Compare
v7 2022-01-13 English Compare
v8 2022-03-09 English Compare
v9 2022-03-09 French Compare
v10 2022-03-28 English Compare
v11 2022-03-28 French Compare
v12 2022-03-31 English Compare
v13 2022-03-31 French Compare
v14 2022-04-13 English Compare
v15 2022-04-13 French Compare
v16 2022-06-08 English Compare
v17 2022-06-08 French Compare
v18 2022-08-04 English Compare
v19 2022-08-04 French Compare
v20 2022-08-24 English Compare

Showing 1 to 20 of 22